Amended Statement of Ownership (sc 13g/a)
February 10 2023 - 01:48PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)*
Pacific Biosciences of California, Inc.
(Name of Issuer)
Common
stock
(Title of Class of Securities)
69404D108
(CUSIP Number)
December 31, 2022
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
* The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a
prior cover page.
The information required in the remainder of this cover
page shall not be deemed to be “filed” for the purpose of
Section 18 of the Securities Exchange Act of 1934 (“Act”) or
otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP
No. 69404D108 |
13G |
Page 2
of 5 Pages |
1. |
NAMES
OF REPORTING PERSONS |
|
ARK
Investment Management LLC |
|
|
2. |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
|
(a)¨ |
|
(b)¨ |
|
3. |
SEC
USE ONLY |
|
|
|
|
4. |
CITIZENSHIP
OR PLACE OF ORGANIZATION |
|
Delaware,
United States |
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
5. |
SOLE
VOTING POWER |
|
24,174,972 |
|
|
6. |
SHARED
VOTING POWER |
|
1,076,590 |
|
|
7. |
SOLE
DISPOSITIVE POWER |
|
25,691,681 |
|
|
8. |
SHARED
DISPOSITIVE POWER |
|
0 |
|
|
9. |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
25,691,681 |
|
|
10. |
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES |
|
¨ |
|
|
11. |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|
11.36% |
|
|
12. |
TYPE
OF REPORTING PERSON |
|
IA |
|
|
CUSIP
No. 69404D108 |
13G |
Page 3
of 5 Pages |
Item 1(a) Name of issuer:
Pacific Biosciences of California, Inc.
Item 1(b) Address of issuer's principal executive
offices:
1305 O’Brien Drive
Menlo Park, CA 94025
Item 2(a) Name of person filing:
ARK Investment Management LLC
Item 2(b) Address or principal business office or, if none,
residence:
ARK Investment Management LLC
200 Central Avenue
St. Petersburg, FL 33701
Item 2(c) Citizenship:
Delaware, United States
Item 2(d) Title of class of securities:
Common stock
Item 2(e) CUSIP No.:
69404D108
Item 3. If this statement is filed pursuant to §§
240.13d-1(b) or 240.13d-2(b) or (c), check whether the
person filing is a:
(a) ¨ Broker or
dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b) ¨ Bank as
defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c) ¨ Insurance
company as defined in section 3(a)(19) of the Act (15 U.S.C.
78c);
(d) ¨ Investment
company registered under section 8 of the Investment Company Act of
1940 (15 U.S.C 80a-8);
(e) x An
investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f) ¨ An employee
benefit plan or endowment fund in accordance with §
240.13d-1(b)(1)(ii)(F);
(g) ¨ A parent
holding company or control person in accordance with §
240.13d-1(b)(1)(ii)(G);
(h) ¨ A savings
associations as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
CUSIP
No. 69404D108 |
13G |
Page 4
of 5 Pages |
(i) ¨ A church
plan that is excluded from the definition of an investment company
under section 3(c)(14) of the Investment Company Act of 1940 (15
U.S.C. 80a-3);
(j) ¨ A non-U.S.
institution in accordance with § 240.13d-1(b)(1)(ii)(J);
(k) ¨ Group, in
accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S.
institution in accordance with § 240.13d-1(b)(1)(ii)(J), please
specify the type of institution: ____
Item 4. Ownership
|
(a) |
Amount beneficially owned: |
25,691,681
11.36%
|
(c) |
Number of shares as to which such
person has: |
(i) Sole power to vote or to direct the vote:
24,174,972
(ii) Shared power to vote or to direct the vote:
1,076,590
(iii) Sole power to dispose or to direct the disposition
of: 25,691,681
(iv) Shared power to dispose or to direct the disposition
of: 0
Item 5. Ownership of 5 Percent or Less of a Class.
Not applicable.
|
Item 6. |
Ownership of More than 5 Percent on Behalf of Another
Person. |
To the knowledge of the Reporting Person, no other person has the
right to receive or the power to direct the receipt of dividends
from, or the proceeds from the sale of, a number of the shares
which represents more than five percent of the number of
outstanding class of the shares.
|
Item 7. |
Identification and
Classification of the Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding Company or Control
Person. |
Not applicable.
|
Item 8. |
Identification and Classification of Members of the
Group. |
Not applicable.
|
Item 9. |
Notice of Dissolution of Group. |
Not applicable.
CUSIP
No. 69404D108 |
13G |
Page 5
of 5 Pages |
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect, other
than activities solely in connection with a nomination under §
240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
The reporting persons agree that this statement is filed on behalf
of each of them.
Dated: February 10, 2023
|
ARK Investment Management LLC |
|
|
|
|
By: |
/s/ Kellen
Carter |
|
|
Name: |
Kellen
Carter |
|
|
Title: |
Chief
Compliance Officer |
Pacific Biosciences of C... (NASDAQ:PACB)
Historical Stock Chart
From May 2023 to Jun 2023
Pacific Biosciences of C... (NASDAQ:PACB)
Historical Stock Chart
From Jun 2022 to Jun 2023